Spotlight Asset Group, Inc. Mustang Bio, Inc. Transaction History

Spotlight Asset Group, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 07, 2021	BUY	$3.02 - $5.16 $875,836 - $1.5 Million	290,012 Added 1895.5%	305,312 $1.01 Million
Q4 2019 Apr 13, 2020	BUY	$2.57 - $4.08 $39,321 - $62,424	15,300 New	15,300 $41,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $35.8M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Spotlight Asset Group, Inc. with notifications on news.